Key Financial Data Of Reporting Company

D.Western Therapeutics Institute, Inc. - Filing #7338952

Concept 2024-01-01 to
2024-03-31
As at
2024-03-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-03-31
As at
2023-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
104,819,000 JPY
428,364,000 JPY
90,000,000 JPY
Ordinary profit (loss)
-320,454,000 JPY
-796,363,000 JPY
-101,330,000 JPY
Net assets
958,805,000 JPY
1,279,764,000 JPY
1,899,068,000 JPY
Total assets
2,117,369,000 JPY
2,373,371,000 JPY
2,852,129,000 JPY
Basic earnings (loss) per share
-9.99
-25.56
-3.14
Diluted earnings per share
Equity-to-asset ratio
0.453 xbrli:pure
0.539 xbrli:pure
0.661 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.